nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—CYP1A2—Fluorouracil—urinary bladder cancer	0.0601	0.286	CbGbCtD
Niclosamide—CYP2C9—Fluorouracil—urinary bladder cancer	0.0541	0.257	CbGbCtD
Niclosamide—CYP1A2—Etoposide—urinary bladder cancer	0.0502	0.238	CbGbCtD
Niclosamide—CYP2C9—Cisplatin—urinary bladder cancer	0.046	0.219	CbGbCtD
Niclosamide—STAT3—prostate gland—urinary bladder cancer	0.0318	0.149	CbGeAlD
Niclosamide—STAT3—epithelium—urinary bladder cancer	0.0234	0.109	CbGeAlD
Niclosamide—STAT3—smooth muscle tissue—urinary bladder cancer	0.0225	0.105	CbGeAlD
Niclosamide—STAT3—renal system—urinary bladder cancer	0.0217	0.101	CbGeAlD
Niclosamide—STAT3—urethra—urinary bladder cancer	0.0213	0.0996	CbGeAlD
Niclosamide—CYP1A2—urine—urinary bladder cancer	0.021	0.098	CbGeAlD
Niclosamide—CYP2C9—urine—urinary bladder cancer	0.0199	0.093	CbGeAlD
Niclosamide—STAT3—female reproductive system—urinary bladder cancer	0.0174	0.0812	CbGeAlD
Niclosamide—STAT3—vagina—urinary bladder cancer	0.0157	0.0735	CbGeAlD
Niclosamide—STAT3—lymph node—urinary bladder cancer	0.0102	0.0475	CbGeAlD
Niclosamide—Clonazepam—NAT2—urinary bladder cancer	0.00799	0.608	CrCbGaD
Niclosamide—CYP1A2—renal system—urinary bladder cancer	0.00513	0.024	CbGeAlD
Niclosamide—CYP2C9—female reproductive system—urinary bladder cancer	0.0039	0.0182	CbGeAlD
Niclosamide—Diflunisal—PTGS2—urinary bladder cancer	0.00273	0.207	CrCbGaD
Niclosamide—Meclofenamic acid—PTGS2—urinary bladder cancer	0.00243	0.185	CrCbGaD
Niclosamide—STAT3—BDNF signaling pathway—SRC—urinary bladder cancer	0.000745	0.00132	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000741	0.00132	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000739	0.00131	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—CDKN1A—urinary bladder cancer	0.000737	0.00131	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—PTEN—urinary bladder cancer	0.000735	0.00131	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—PTEN—urinary bladder cancer	0.000731	0.0013	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CXCL8—urinary bladder cancer	0.000728	0.00129	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—ERBB2—urinary bladder cancer	0.000708	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000693	0.00123	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—KRAS—urinary bladder cancer	0.000691	0.00123	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—RB1—urinary bladder cancer	0.00069	0.00123	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CDKN1A—urinary bladder cancer	0.000683	0.00121	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—SRC—urinary bladder cancer	0.000682	0.00121	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—PTEN—urinary bladder cancer	0.000681	0.00121	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000681	0.00121	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—SRC—urinary bladder cancer	0.000678	0.00121	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—HRAS—urinary bladder cancer	0.000675	0.0012	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TNF—urinary bladder cancer	0.000675	0.0012	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CDKN1A—urinary bladder cancer	0.000668	0.00119	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—PTEN—urinary bladder cancer	0.000666	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—EGFR—urinary bladder cancer	0.000664	0.00118	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000661	0.00117	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—HRAS—urinary bladder cancer	0.00066	0.00117	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDKN1A—urinary bladder cancer	0.000656	0.00117	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000645	0.00115	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000633	0.00113	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—SRC—urinary bladder cancer	0.000632	0.00112	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—KRAS—urinary bladder cancer	0.000628	0.00112	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—SRC—urinary bladder cancer	0.000618	0.0011	CbGpPWpGaD
Niclosamide—STAT3—Disease—LIG1—urinary bladder cancer	0.000615	0.00109	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NCOR1—urinary bladder cancer	0.00061	0.00108	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000607	0.00108	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CDKN1A—urinary bladder cancer	0.000605	0.00108	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PTEN—urinary bladder cancer	0.000603	0.00107	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—EGFR—urinary bladder cancer	0.000597	0.00106	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—EGFR—urinary bladder cancer	0.000594	0.00106	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—RHOA—urinary bladder cancer	0.000588	0.00105	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—HRAS—urinary bladder cancer	0.000587	0.00104	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BIRC3—urinary bladder cancer	0.000586	0.00104	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000583	0.00104	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000575	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—KRAS—urinary bladder cancer	0.000564	0.001	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—KRAS—urinary bladder cancer	0.000562	0.000998	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—SRC—urinary bladder cancer	0.00056	0.000995	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000555	0.000987	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—EGFR—urinary bladder cancer	0.000554	0.000985	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CXCL8—urinary bladder cancer	0.00055	0.000978	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—ERBB2—urinary bladder cancer	0.000544	0.000968	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HDAC4—urinary bladder cancer	0.000542	0.000963	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—EGFR—urinary bladder cancer	0.000542	0.000963	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—HRAS—urinary bladder cancer	0.000533	0.000948	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000524	0.000932	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—KRAS—urinary bladder cancer	0.000523	0.00093	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—KRAS—urinary bladder cancer	0.000512	0.00091	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	0.000502	0.000892	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000498	0.000886	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000496	0.000882	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000492	0.000874	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—EGFR—urinary bladder cancer	0.00049	0.000872	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000485	0.000862	CbGpPWpGaD
Niclosamide—STAT3—Immune System—RBX1—urinary bladder cancer	0.000481	0.000855	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CDK4—urinary bladder cancer	0.000481	0.000855	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—HRAS—urinary bladder cancer	0.00048	0.000853	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—HRAS—urinary bladder cancer	0.000477	0.000849	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—EP300—urinary bladder cancer	0.000472	0.000839	CbGpPWpGaD
Niclosamide—STAT3—Disease—ENO2—urinary bladder cancer	0.000469	0.000833	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000466	0.000829	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CDKN1A—urinary bladder cancer	0.000465	0.000827	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PTEN—urinary bladder cancer	0.000464	0.000825	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—KRAS—urinary bladder cancer	0.000463	0.000824	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000458	0.000814	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GLI1—urinary bladder cancer	0.000454	0.000807	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000452	0.000804	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—urinary bladder cancer	0.000447	0.000794	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—HRAS—urinary bladder cancer	0.000445	0.000791	CbGpPWpGaD
Niclosamide—STAT3—Disease—RBX1—urinary bladder cancer	0.000444	0.00079	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PPARG—urinary bladder cancer	0.000437	0.000777	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000436	0.000776	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—HRAS—urinary bladder cancer	0.000435	0.000773	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—SRC—urinary bladder cancer	0.00043	0.000765	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000421	0.000748	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CREBBP—urinary bladder cancer	0.00042	0.000746	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000399	0.000709	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000398	0.000708	CbGpPWpGaD
Niclosamide—STAT3—Disease—JAG1—urinary bladder cancer	0.000398	0.000707	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	0.000394	0.0007	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000386	0.000687	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—RHOA—urinary bladder cancer	0.00038	0.000675	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—EGFR—urinary bladder cancer	0.000377	0.000671	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000373	0.000663	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000369	0.000657	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNA2—urinary bladder cancer	0.000369	0.000656	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	0.000362	0.000644	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KRAS—urinary bladder cancer	0.000356	0.000634	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—ERBB2—urinary bladder cancer	0.000351	0.000625	CbGpPWpGaD
Niclosamide—STAT3—Immune System—S100B—urinary bladder cancer	0.000349	0.00062	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000348	0.000619	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—urinary bladder cancer	0.000338	0.0006	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000337	0.000598	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000332	0.000589	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000332	0.000589	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000322	0.000573	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000322	0.000573	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000313	0.000557	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RBX1—urinary bladder cancer	0.000311	0.000553	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000309	0.00055	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	0.000308	0.000548	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—HRAS—urinary bladder cancer	0.000303	0.000539	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—urinary bladder cancer	0.000301	0.000536	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TSC1—urinary bladder cancer	0.000293	0.00052	CbGpPWpGaD
Niclosamide—STAT3—Disease—NCOR1—urinary bladder cancer	0.00029	0.000515	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000289	0.000514	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000288	0.000512	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000288	0.000511	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EP300—urinary bladder cancer	0.000286	0.000508	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000284	0.000505	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000283	0.000502	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000283	0.000502	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—JAG1—urinary bladder cancer	0.000278	0.000495	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—SRC—urinary bladder cancer	0.000278	0.000494	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERCC2—urinary bladder cancer	0.000272	0.000484	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000269	0.000478	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000269	0.000478	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000268	0.000476	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000267	0.000475	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000264	0.00047	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTHFR—urinary bladder cancer	0.000256	0.000455	CbGpPWpGaD
Niclosamide—STAT3—Disease—TERT—urinary bladder cancer	0.000255	0.000454	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGFR3—urinary bladder cancer	0.000254	0.000451	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000246	0.000438	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EGFR—urinary bladder cancer	0.000244	0.000433	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000243	0.000432	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGFR3—urinary bladder cancer	0.000234	0.000416	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—urinary bladder cancer	0.000232	0.000412	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—KRAS—urinary bladder cancer	0.00023	0.000409	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000227	0.000403	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—S100B—urinary bladder cancer	0.000225	0.000401	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CREBBP—urinary bladder cancer	0.000216	0.000384	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDH1—urinary bladder cancer	0.000214	0.000381	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NCOR1—urinary bladder cancer	0.000203	0.00036	CbGpPWpGaD
Niclosamide—STAT3—Disease—CREBBP—urinary bladder cancer	0.000199	0.000354	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—HRAS—urinary bladder cancer	0.000196	0.000348	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000192	0.000341	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000182	0.000324	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000182	0.000324	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERBB2—urinary bladder cancer	0.000181	0.000321	CbGpPWpGaD
Niclosamide—STAT3—Disease—RHOA—urinary bladder cancer	0.00018	0.000321	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000179	0.000318	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TERT—urinary bladder cancer	0.000179	0.000318	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERBB2—urinary bladder cancer	0.000167	0.000297	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	0.000167	0.000296	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000164	0.000292	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGFR3—urinary bladder cancer	0.000164	0.000292	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—urinary bladder cancer	0.000164	0.000291	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTGS2—urinary bladder cancer	0.000163	0.00029	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ESR1—urinary bladder cancer	0.000159	0.000283	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000156	0.000277	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000156	0.000277	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDKN1A—urinary bladder cancer	0.000155	0.000275	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTEN—urinary bladder cancer	0.000154	0.000274	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000153	0.000272	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	0.00015	0.000267	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EP300—urinary bladder cancer	0.000147	0.000261	CbGpPWpGaD
Niclosamide—STAT3—Immune System—SRC—urinary bladder cancer	0.000143	0.000254	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN1A—urinary bladder cancer	0.000143	0.000254	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTEN—urinary bladder cancer	0.000142	0.000253	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000142	0.000253	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	0.000142	0.000252	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CREBBP—urinary bladder cancer	0.00014	0.000248	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	0.000138	0.000245	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF1—urinary bladder cancer	0.000138	0.000245	CbGpPWpGaD
Niclosamide—STAT3—Disease—EP300—urinary bladder cancer	0.000136	0.000241	CbGpPWpGaD
Niclosamide—STAT3—Disease—SRC—urinary bladder cancer	0.000132	0.000235	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000128	0.000228	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RHOA—urinary bladder cancer	0.000126	0.000224	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGFR—urinary bladder cancer	0.000125	0.000223	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000121	0.000215	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KRAS—urinary bladder cancer	0.000118	0.00021	CbGpPWpGaD
Niclosamide—STAT3—Disease—MYC—urinary bladder cancer	0.000118	0.00021	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	0.000118	0.00021	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB2—urinary bladder cancer	0.000117	0.000208	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGFR—urinary bladder cancer	0.000116	0.000206	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—urinary bladder cancer	0.000111	0.000197	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000111	0.000197	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	0.00011	0.000196	CbGpPWpGaD
Niclosamide—STAT3—Disease—KRAS—urinary bladder cancer	0.000109	0.000194	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—urinary bladder cancer	0.000106	0.000188	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000106	0.000188	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCND1—urinary bladder cancer	0.000103	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HRAS—urinary bladder cancer	0.000101	0.000179	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—urinary bladder cancer	0.0001	0.000178	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN1A—urinary bladder cancer	9.99e-05	0.000178	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	9.97e-05	0.000177	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTEN—urinary bladder cancer	9.97e-05	0.000177	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EP300—urinary bladder cancer	9.51e-05	0.000169	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.45e-05	0.000168	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TYMP—urinary bladder cancer	9.43e-05	0.000168	CbGpPWpGaD
Niclosamide—STAT3—Disease—HRAS—urinary bladder cancer	9.29e-05	0.000165	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SRC—urinary bladder cancer	9.24e-05	0.000164	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.05e-05	0.000161	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	8.61e-05	0.000153	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NAT2—urinary bladder cancer	8.52e-05	0.000152	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MYC—urinary bladder cancer	8.28e-05	0.000147	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGFR—urinary bladder cancer	8.1e-05	0.000144	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	7.97e-05	0.000142	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	7.97e-05	0.000142	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.93e-05	0.000141	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	7.73e-05	0.000138	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KRAS—urinary bladder cancer	7.65e-05	0.000136	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.62e-05	0.000135	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—RRM2—urinary bladder cancer	7.36e-05	0.000131	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	6.81e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ENO2—urinary bladder cancer	6.81e-05	0.000121	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—urinary bladder cancer	6.8e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.77e-05	0.00012	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	6.61e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.51e-05	0.000116	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HRAS—urinary bladder cancer	6.51e-05	0.000116	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	6.43e-05	0.000114	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.24e-05	0.000111	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NQO1—urinary bladder cancer	5.49e-05	9.76e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.44e-05	9.67e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	5.36e-05	9.53e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.33e-05	9.47e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.19e-05	9.22e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	4.98e-05	8.86e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	4.93e-05	8.76e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	4.93e-05	8.76e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.72e-05	8.39e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.65e-05	8.26e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.63e-05	8.23e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	4.58e-05	8.14e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.43e-05	7.88e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.35e-05	7.74e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TYMS—urinary bladder cancer	4.26e-05	7.57e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.21e-05	7.48e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.21e-05	7.48e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GPX1—urinary bladder cancer	4.03e-05	7.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.96e-05	7.04e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	3.72e-05	6.61e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.53e-05	6.28e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.39e-05	6.03e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.02e-05	5.36e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.9e-05	5.15e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.78e-05	4.94e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.42e-05	4.31e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.37e-05	4.22e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.31e-05	4.11e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.07e-05	3.68e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.97e-05	3.51e-05	CbGpPWpGaD
